About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: May 13, 2011
Weekly Roundup – 5/13/11
It is gloomy outside. I am gloomy inside. To distract me, I will report a little of what happened this week: FDA Seeks Input on Development of User Fee Program for Biosimilars – The agency has enunciated principles for the … Continue reading
Posted in Uncategorized
Comments Off on Weekly Roundup – 5/13/11